The National Biotechnology Development Agency has identified three drugs to be repositioned and repurposed for the treatment and eradication of Lassa fever.
Prof. Abdullahi Mustapha, Director-General of National Biotechnology Development Agency, disclosed this in an interview with the News Agency of Nigeria in Abuja.
Mustapha said scientists at the Genetics, Genomics and Bioinformatics Department of the agency, led by its Director, Prof. Oyekanmi Nash, in collaboration with other researchers spearheaded the research.
This is National Biotechnology Development Agency contribution towards finding a lasting solution to Lassa fever disease in Nigeria.
He expressed optimism that the drugs would address the challenges faced in treating patients diagnosed with Lassa fever ailment.
He added that with the breakthrough the challenge was to intensify surveillance and response by ensuring availability of diagnostic centres across most affected regions.
Prof. Oyekanmi Nash, Director of Genetics, Genomics and Bioinformatics of the NABDA, noted that Lassa fever is a ravishing disease peculiar to Nigeria and West Africa.
He said Lassa fever had been without drugs in Nigeria for almost 50 years.